바이오닉 아이 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 최종사용자별, 지역별, 경쟁(2020-2030년)
Bionic Eye Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (External Eye, Implanted Eye), By End User (Hospitals, Outpatient Facilities, Research and Manufacturing), By Region, & Competition, 2020-2030F
상품코드:1748875
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 바이오닉 아이 시장은 2024년에는 3억 2,215만 달러에 달하며, 2030년에는 6억 1,209만 달러에 달할 전망이며, 예측 기간 중 CAGR로 11.25%의 성장이 예측됩니다.
이 신흥 분야는 생명공학, 인공지능, 신경공학의 발전으로 의료기기와 신경보철의 기술 혁신의 최전선에 있습니다. 바이오닉 아이는 망막 이식에서 브레인 머신 인터페이스(BMI)에 이르기까지 심각한 시각 장애나 영구적 실명으로 고통받는 사람들의 부분적인 시력 회복을 목표로 하고 있습니다. 기술의 고도화, 임상 연구의 확대, 난치성 시력 손실의 유병률 증가는 시장 가속화에 기여하고 있으며, AI 기반 이미지 처리, 무선 연결 및 머신러닝의 통합은 기기의 성능과 사용자 성과를 더욱 향상시키고 있습니다. 임상 범위가 망막 질환에서 더 광범위한 신경 장애로 확대됨에 따라 바이오닉 아이 시장은 환자 영향과 상업적 기회 모두에서 혁신적인 성장을 이룰 준비가 되어 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
3억 2,215만 달러
시장 규모 : 2030년
6억 1,209만 달러
CAGR : 2025-2030년
11.25%
급성장 부문
외안부
최대 시장
북미
시장 성장 촉진요인
시력 상실과 치료 불가능한 실명의 유병률 증가
주요 시장 이슈
높은 개발 및 배포 비용
주요 시장 동향
뇌-기계 인터페이스(BMI)와 신경 보철의 발전
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 바이오닉 아이 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
유형별(외안부, 이식눈)
최종사용자별(병원, 외래 시설, 연구·제조)
지역별
기업별(2024)
시장 맵
제6장 북미의 바이오닉 아이 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 바이오닉 아이 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 바이오닉 아이 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 바이오닉 아이 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 바이오닉 아이 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
합병과 인수
제13장 세계의 바이오닉 아이 시장 : SWOT 분석
제14장 경쟁 구도
Second Sight Medical Products LLC
Nidek Co. Ltd.
Nano Retina Ltd.
MetaModal LLC
Biomedical Technologies S.L.
Bionic Vision Technologies
Pixium Vision
Monash Vision Group
제15장 전략적 제안
제16장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Bionic Eye Market was valued at USD 322.15 Million in 2024 and is projected to reach USD 612.09 Million by 2030, growing at a CAGR of 11.25% during the forecast period. This emerging sector is at the forefront of medical device and neuroprosthetics innovation, driven by advances in biotechnology, artificial intelligence, and neural engineering. Bionic eyes-ranging from retinal implants to brain-machine interfaces-aim to restore partial vision in individuals suffering from profound visual impairment or permanent blindness. Increasing technological sophistication, expanding clinical research, and rising prevalence of incurable vision loss are all contributing to the market's acceleration. The integration of AI-driven imaging, wireless connectivity, and machine learning is further enhancing device performance and user outcomes. As the clinical scope extends from retinal conditions to broader neurological impairments, the bionic eye market is poised for transformative growth in both patient impact and commercial opportunity.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 322.15 Million
Market Size 2030
USD 612.09 Million
CAGR 2025-2030
11.25%
Fastest Growing Segment
External Eye Segment
Largest Market
North America
Key Market Drivers
Rising Prevalence of Vision Loss and Untreatable Blindness
The increasing incidence of irreversible vision loss due to inherited retinal diseases, age-related macular degeneration (AMD), glaucoma, and optic nerve atrophy is a primary factor fueling demand for bionic eye systems. These conditions frequently progress to stages where existing treatments-such as medications, surgeries, or laser therapies-fail to preserve or restore sight. Globally, more than 1.5 million individuals are affected by hereditary retinal disorders, and approximately 43 million people were estimated to be completely blind in 2020. With aging populations and lifestyle-related health risks such as diabetes on the rise, the global burden of blindness is expected to increase. Bionic eye technologies, including retinal prostheses and neural implants, provide an alternative approach by transmitting visual data directly to the brain or bypassing damaged retinal cells. For patients who no longer respond to conventional therapies, these systems represent a critical solution, filling a treatment void and offering new hope for functional visual recovery.
Key Market Challenges
High Development and Deployment Costs
The complexity of bionic eye systems-requiring cutting-edge microelectronics, neurosensory interfaces, and high-precision surgical procedures-results in substantial development and operational costs. Total treatment costs, including device implantation, patient rehabilitation, and post-operative support, often place the technology beyond the reach of many healthcare providers and patients, particularly in low- and middle-income regions. Limited insurance reimbursement further hinders accessibility. This cost barrier has slowed the pace of adoption and restricted market entry primarily to specialized centers in high-income countries, impeding broader market penetration.
Key Market Trends
Advancements in Brain-Machine Interface (BMI) and Neuroprosthetics
A transformative trend in the bionic eye market is the integration of brain-machine interface technologies, which allow direct communication between external image sensors and the visual cortex. This bypasses damaged optic nerves or retinal pathways, enabling potential restoration of higher-order visual functions such as object identification and spatial awareness. Innovations in electrode array design, neural decoding algorithms, and bio-compatible materials are supporting the development of more natural and responsive visual systems. As these advancements gain traction, next-generation bionic eye devices are evolving beyond basic light detection to provide richer, more functional visual experiences-attracting growing interest from researchers, investors, and medical institutions.
Key Market Players
Second Sight Medical Products LLC
Nidek Co. Ltd.
Nano Retina Ltd.
MetaModal LLC
Biomedical Technologies S.L.
Bionic Vision Technologies
Pixium Vision
Monash Vision Group
Report Scope:
In this report, the Global Bionic Eye Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Bionic Eye Market, By Type:
External Eye
Implanted Eye
Bionic Eye Market, By End User:
Hospitals
Outpatient Facilities
Research and Manufacturing
Bionic Eye Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bionic Eye Market.
Available Customizations:
Global Bionic Eye market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Bionic Eye Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (External Eye, Implanted Eye)
5.2.2. By End User (Hospitals, Outpatient Facilities, Research and Manufacturing)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Bionic Eye Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Bionic Eye Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By End User
6.3.2. Canada Bionic Eye Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By End User
6.3.3. Mexico Bionic Eye Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By End User
7. Europe Bionic Eye Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Bionic Eye Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By End User
7.3.2. United Kingdom Bionic Eye Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By End User
7.3.3. Italy Bionic Eye Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By End User
7.3.4. France Bionic Eye Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By End User
7.3.5. Spain Bionic Eye Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By End User
8. Asia-Pacific Bionic Eye Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End User
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Bionic Eye Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By End User
8.3.2. India Bionic Eye Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By End User
8.3.3. Japan Bionic Eye Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By End User
8.3.4. South Korea Bionic Eye Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By End User
8.3.5. Australia Bionic Eye Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By End User
9. South America Bionic Eye Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End User
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Bionic Eye Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By End User
9.3.2. Argentina Bionic Eye Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By End User
9.3.3. Colombia Bionic Eye Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By End User
10. Middle East and Africa Bionic Eye Market Outlook
